By proceeding, you agree to our Terms of Use and Privacy Policy.
John is currently Vice President of Patient and Health Impact for Pfizer’s Essential Health business unit, which has worldwide sales of more than $20B from a portfolio of over 700 molecules including biosimilars, sterile injectables and solid oral do
Talks About #talent #HR
Preferred Locations #NorthAmerica
World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 250 speakers, multiple streams and over 1000 attendees from pharma, biotech and Payers/HTA’s.
